Time period | Treatment regimens | TC (mmol/L) | LDL (mmol/L) | Remarks |
2014.08 | - | 14.10 | 12.47 | pretherapy |
2014.8-2014.9 | A 20 mg QD | 12.44 | 10.07 | normal liver function |
2014.9-2015.5 | A 40 mg QD | 11.52 | 9.33 | ALT70U/L, AST54U/L |
2015.5-2015.7 | A 20 mg QD; E 10 mg QD PPC 228 mg TID | 9.6 | 8.08 | ALT73U/L, AST64U/L |
2015.7-2016.02 | A 40 mg QD; E10 mg QD PPC 228 mg TID | 13.74 | 11.3 | ALT54U/L, AST43U/L |
2016.02 till now | A 40 mg QD; E 10 mg QD PPC 456 mg TID | 11.46 | 8.32 | ALT49U/L, AST31U/L |